Re: [biotech-40] Sign up now! Biotech and innovation in NYC: insights with Dr. Marc Tessier-Lavigne March March 28 at 5:30 pm at Proskauer Rose; news

From: keren
Sent on: Thursday, March 14, 2013 1:50 AM
Great event! I would come. 

On Thu, Mar 14, 2013 at 1:06 AM, John Wilson <[address removed]> wrote:
Dear NYC Bio members,

Spring is nearly here and changes abound. To begin, apologies for the silence; my family grew by one at the end of January and it's been...busy.

* First, for those of you generating IP, remember that Saturday morning at 12:01 (March 16th), the first-to-file provision of American Invents Act starts. Anyone who hasn't filed for a patent must do so before Friday to keep a first-to-invent date. Of course that be a provisional ($125 for small entities, to go down to $65 for micro entities on the 18th), but the clock is ticking. I recommend assuming that the EFS-Web will crash on Friday. Don't sleep, file! (Well, that will be me at least...)

* Second, please join us March 28th at 5:30 pm for a NYC Bio Legend event, "Biotech and innovation in NYC: insights with Dr. Marc Tessier-Lavigne" generously hosted by Proskauer Rose with refreshments generously provided by the NYU Stern School of Business and Proskauer Rose. Register at ($10 students and postdocs, $15 everybody else and see below regarding Eventbrite).

As you guys know, Marc held a named professorship at Stanford before being recruited to Genentech, where he became the Executive VP of Research and CSO. Of course as you guys also know, the Rockefeller University just had to have someone of that caliber at their helm and they managed to extract him from the Bay Area. Marc is uniquely, exceptionally qualified to give us some truly helpful input. He'll be talking about his own experiences, share his thoughts about biotech and academia and give us both big-picture and regional biotech insight. Don't miss this one.

NOTE: We're moving our registration to Eventbrite. Meetup has treated us really well, we like it and I'm more than a bit loathe to make this change. However, we're now on LinkedIn as well as Meetup with more channels to come. Please bear with us during our transitions.

* Third, Health 2.0 has an event this coming Monday the 18th: Doctors 2.0 Series: The Physicians Weigh In on Healthcare Innovation. "Join us as we hear from thought leaders and practicing physicians on the innovations we have been seeing over the past few years.  Hosted at the New York Academy of Medicine, this is by far the largest Health 2.0 NYC event ever.  Join over 400 healthcare leaders that have registered for this event!" Leave it to Alex Fair to cover some of the most important topics in healthcare out there. RSVP at ($20 online, $30 at the door) and don't miss this one either.

* Fourth, lots continues to happen behind the scenes at NYC Bio. Some of you may have seen that our website is finally [finally!] back on (and it's changing as I write). Soon you'll see a company directory function there (like LinkSV for Silicon Valley) as well as a map populated from the directory that also shows the biotech resources of the greater NYC region (universities, incubators, etc.). As soon as the directory up, please start populating your companies and those of which you know. You'll also see a universal calendar for biotech events (send those too) and probably a jobs section. In addition, we're planning more and more diverse events; stay tuned there. Our collaborative incubator/accelerator project with MedStartr is coming online and quite exciting; stay tuned there too. Please note we're open to names here people; apparently our first thought, MOIST, as in a Magnet (Machine?) Of Innovation in Science and Technology--squarely between wet and dry, which is in fact the plan--is at or near the top of word aversion. Great for remembering but if everybody hates it...

* Fifth, you'll soon see the NYC Bio Blog light up at our website. A highly insightful conference on biotech patents concluded today (yesterday) at Cold Spring Harbor Laboratory; I attended and will be posting some insights. IP peoples: if you're polishing amicus briefs, please make sure they're really, really good. The consensus was that Myriad is going down with the possible worst-case consequence that patents of all things originating in nature could be opened up wide to litigation (and yes, we're talking small molecules too). For those who aren't following the case, it has the potential to kill the patentability of genes (read: diagnostics, antibodies, etc.). Oral arguments start next month. Myriad was confident. That was the voice of confidence in >25 attendees.

* Sixth and finally, we are actively seeking funding. NYC Bio has been both active and quiet through the years, completely as a function of the volunteers who run it. Our goals now outstrip that model and by the end of the year, we aim to have a full time Executive Director. So, if you are a person who finds funding, a person interested in funding us and making a difference, or can otherwise assist with that cold-hard-cash that makes the world go around, please email me.

Happy bioteching, best,


Please Note: If you hit "REPLY", your message will be sent to everyone on this mailing list ([address removed])
This message was sent by John Wilson ([address removed]) from NYC Bio Meetup.
To learn more about John Wilson, visit his/her member profile
Set my mailing list to email me As they are sent | In one daily email | Don't send me mailing list messages

Meetup, POB 4668 #37895 NY NY USA 10163 | [address removed]

People in this
Meetup are also in:

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy